Investing.com -- Scholar Rock Holding Corp (NASDAQ: SRRK) stock surged 16.4% after the company announced positive results from its Phase 2 EMBRAZE trial evaluating apitegromab in combination with ...

Instead of focusing on weight loss, focus on developing a healthy body composition—it offers way more health benefits. Here ...

Passionfruit is another healthy kitchen staple you can (practically) eat as much as you want without gaining weight. One ...

Jonathan Van Ness has unveiled their major body transformation, after 'confessing' to fans that they had being using ...

A study presented at the American Society for Metabolic and Bariatric Surgery highlighted that bariatric surgeries, ...

Around 1.5 million Brits are now taking weight-loss drugs, such as Mounjaro, and pharmacists are warning users to be careful in the heatwave ...

Scholar Rock’s investigational spinal muscular atrophy drug helped patients taking Eli Lilly’s obesity blockbuster Zepbound ...

Discover why weight loss becomes harder for women after 30. These hormonal and metabolic changes explain the struggle ...

A new study is showing the effectiveness of GLP-1 medication, commonly referred to as weight loss drugs, and how they stack ...

It wasn't so long ago that Novo Nordisk (NYSE: NVO), a Denmark-based pharmaceutical company, seemed to be firing on all cylinders. CagriSema, an investigational weight loss medicine, performed well in ...

Bariatric surgeries led to about five-times more weight loss than weekly injections of popular GLP-1 drugs, according to data ...

Curious about Mitolyn? We dug through Mitolyn supplement reviews to reveal the truth—no fluff, just facts. Here's what worked and what didn't ...